COLLPLANT BIOTECHNOLOGIES LT (CLGN:NASDAQ)
$0.3923 0.0083 (2.1615%)
Analysed COLLPLANT BIOTECHNOLOGIES LT (CLGN:NASDAQ) News Sources
CollPlant Issues Letter to Shareholders
13-04-2026
yahoo.com
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
26-03-2026
yahoo.com
CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement
24-03-2026
yahoo.com
CollPlant Biotechnologies Launches Redesigned Corporate Website
18-03-2026
yahoo.com
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS
11-03-2026
yahoo.com
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler
26-02-2026
yahoo.com
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex
23-02-2026
yahoo.com
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments
17-02-2026
yahoo.com
When Will CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Turn A Profit?
08-02-2026
yahoo.com
CollPlant to sell 1.6M ordinary shares at $1.25 in registered direct offering
06-02-2026
yahoo.com
What is the current price of COLLPLANT BIOTECHNOLOGIES LT (CLGN:NASDAQ)?
The current price of COLLPLANT BIOTECHNOLOGIES LT (CLGN:NASDAQ) is $0.3923.
COLLPLANT BIOTECHNOLOGIES LT (CLGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of COLLPLANT BIOTECHNOLOGIES LT (CLGN:NASDAQ) since the previous trading day is $0.0083.
COLLPLANT BIOTECHNOLOGIES LT (CLGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of COLLPLANT BIOTECHNOLOGIES LT (CLGN:NASDAQ) since the previous trading day is 2.1615%.
What is the most recent average sentiment score for COLLPLANT BIOTECHNOLOGIES LT (CLGN:NASDAQ)?
The most recent average sentiment score for COLLPLANT BIOTECHNOLOGIES LT (CLGN:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for COLLPLANT BIOTECHNOLOGIES LT (CLGN:NASDAQ)?
The most recent sentiment for COLLPLANT BIOTECHNOLOGIES LT (CLGN:NASDAQ) is .
SEC-8K** Filing Available For COLLPLANT BIOTECHNOLOGIES LT (CLGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.